NCCAM To Initiate Osteoarthritis Alt. Med. Clinical Trials With NIAMS
This article was originally published in The Tan Sheet
Executive Summary
Two studies evaluating alternative therapies for osteoarthritis will be conducted in FY 2000 and sponsored jointly by NIH's National Center for Complementary & Alternative Medicine and the National Institute of Arthritis and Musculoskeletal and Skin Diseases.
You may also be interested in...
NCCAM Sponsoring First Glucosamine/Chondroitin Sulfate Multicenter Study
NCCAM is sponsoring the first U.S. multicenter study investigating the "short-term (16 weeks) effectiveness of glucosamine and chondroitin sulfate in reducing pain and improving function in a large number of patients with osteoarthritis of the knee," the National Institutes of Health National Center for Complementary & Alternative Medicine announced.
NCCAM Sponsoring First Glucosamine/Chondroitin Sulfate Multicenter Study
NCCAM is sponsoring the first U.S. multicenter study investigating the "short-term (16 weeks) effectiveness of glucosamine and chondroitin sulfate in reducing pain and improving function in a large number of patients with osteoarthritis of the knee," the National Institutes of Health National Center for Complementary & Alternative Medicine announced.
NCCAM Sponsoring First Glucosamine/Chondroitin Sulfate Multicenter Study
NCCAM is sponsoring the first U.S. multicenter study investigating the "short-term (16 weeks) effectiveness of glucosamine and chondroitin sulfate in reducing pain and improving function in a large number of patients with osteoarthritis of the knee," the National Institutes of Health National Center for Complementary & Alternative Medicine announced.